Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19Michael A. Thompson, KM Steve Lo, Elizabeth Robilotti et al.|JAMA Oncology|2021Cited by 185
IgM myeloma: A multicenter retrospective study of 134 patientsJorge J. Castillo, Morie A. Gertz, Artur Jurczyszyn et al.|American Journal of Hematology|2017Cited by 49
Comprehensive Characterization of the Multiple Myeloma Immune Microenvironment Using Integrated scRNA-seq, CyTOF, and CITE-seq AnalysisLijun Yao, Li Ding, Reyka G. Jayasinghe et al.|Cancer Research Communications|2022Cited by 40
Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myelomaErica K. Barnell, Lukas D. Wartman, Zachary L. Skidmore et al.|Blood Advances|2022Cited by 19
A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myelomaWilliam C. Pilcher, Shaji Kumar, Lijun Yao et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 14